X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accesswire.com/852150/acne-vulgaris-treatment-prarazlo-tazarotene-lotion-0045-now-available-to-patients-through-british-columbia-pharmacare-public-drug-plan
https://www.accesswire.com/723138/Ortho-Dermatologics-to-Present-New-Data-at-the-2022-Innovations-in-Dermatology-Conference
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214136
https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-tazarotene-topical-solution-1659343002.pdf
https://www.prnewswire.com/news-releases/ortho-dermatologics-to-present-new-data-at-the-2021-fall-clinical-dermatology-conference-301402874.html
https://www.prnewswire.com/news-releases/ortho-dermatologics-announces-publication-of-pivotal-phase-3-data-on-arazlo-tazarotene-lotion-0-045-in-the-journal-of-drugs-in-dermatology-jdd-300985477.html
https://www.cnbc.com/2019/04/25/shares-of-bausch-health-formerly-known-as-valeant-rise-3percent-on-fda-approval-for-psoriasis-treatment.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211175
https://www.fiercepharma.com/marketing/cosmo-to-give-bausch-health-sales-a-run-latest-fda-nod-for-xifaxan-rival
https://www.prnewswire.com/news-releases/almirall-acquires-allergan-us-medical-dermatology-portfolio-300716808.html
https://www.fiercepharma.com/pharma/bausch-health-quickly-revives-fda-quest-for-significant-7-hopeful-duobrii
http://www.pharmatimes.com/news/almirall_acquires_allergans_us_dermatology_portfolio_for_$650_million_1246917
https://www.in-pharmatechnologist.com/Article/2018/06/19/US-FDA-rejects-Valeant-s-Duobrii-for-plaque-psoriasis
https://www.fiercepharma.com/pharma/valeant-dealt-a-major-setback-as-psoriasis-dual-drug-lotion-duobrii-fails-to-impress-fda
https://endpts.com/valeant-nosedives-on-crl-for-plaque-psoriasis-raising-concerns-over-touted-1b-pipeline/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-11-2018-1523421880.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208662
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208258
http://www.dddmag.com/news/2016/12/valeant-pharmaceuticals-posts-phase-3-results-psoriasis-treatment
http://www.prnewswire.com/news-releases/sienna-biopharmaceuticals-acquires-creabilis-plc-300373769.html
http://www.fiercepharma.com/manufacturing/allergan-recalling-tazorac-acne-cream
Market Place
Share 
